Bleeding risk and safety profile related to the use of eptifibatide: a current review. - Wikidata - wikimedia - TriplyDB

Bleeding risk and safety profile related to the use of eptifibatide: a current review.

Bleeding risk and safety profile related to the use of eptifibatide: a current review.

http://www.wikidata.org/entity/Q37974686

about

Efficacy and safety of eptifibatide versus tirofiban in acute coronary syndrome patients: A systematic review and meta-analysis.Peptidomimetic therapeutics: scientific approaches and opportunities.

P2860

Q33441432-59B8A5A8-0549-4D50-A0CF-3BADDD967F8D Q39011193-54652CD8-784D-4AA8-93A4-A5ABB45774FC

P2860

Bleeding risk and safety profile related to the use of eptifibatide: a current review.

http://www.wikidata.org/entity/Q37974686

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Bleeding risk and safety profile related to the use of eptifibatide: a current review.

@en

Bleeding risk and safety profile related to the use of eptifibatide: a current review.

@nl

type

label

Bleeding risk and safety profile related to the use of eptifibatide: a current review.

@en

Bleeding risk and safety profile related to the use of eptifibatide: a current review.

@nl

prefLabel

Bleeding risk and safety profile related to the use of eptifibatide: a current review.

@en

Bleeding risk and safety profile related to the use of eptifibatide: a current review.

@nl

P1433

Q37974686-5ED65B84-7924-43AC-96E7-681A38CDCD61

P1476

Q37974686-5F72D022-F823-405D-BDAF-3C77292FECF3

P2093

Q37974686-178ACA5E-34CB-4EC2-AA7D-1E785B398C7D

Q37974686-C2DA153E-814E-46C8-904D-4CF76290DE34

Q37974686-E1493B31-3A71-4CB3-A1FC-CEF2DBE21350

P2860

Q37974686-018C61D1-E8CA-4644-8C26-20DCCA66A921

Q37974686-069B3ED8-4851-4A65-AAE7-8E87AF244E30

Q37974686-1A448FC1-094A-4316-9095-5CF0B83DA03E

Q37974686-1AF1E1FF-5A3A-48B2-89C9-FDB8D0760DE2

Q37974686-1C309709-32FF-4979-B390-3EEE8F88B93A

Q37974686-1F8EE339-0243-4535-880A-709AF0F9CF51

Q37974686-1FA349E6-D398-4741-8D2C-5BCC8662F275

Q37974686-22812394-3CC4-439A-A19A-932832CCECDD

Q37974686-236421A8-E686-44E5-82DF-F2EAD35C9732

Q37974686-252A505A-B724-4189-A891-675AFB4E1037

P304

Q37974686-1F1B2190-AEC9-4113-88A8-0D1E762E4195

P31

Q37974686-F69D3DA5-674C-4B62-8391-F7CA29A6754E

P356

Q37974686-8626FA07-730B-4DB9-8619-64AD770CF47A

P407

Q37974686-6815C11F-8819-42E7-A316-A826CA312EED

P433

Q37974686-2736DA03-C206-46AD-A6FC-7F16A7FC246D

P478

Q37974686-02E70F22-C386-4206-BC68-A6053907EA75

P577

Q37974686-FBEB7C7E-3AC6-4603-A3E5-8CB4B506C697

P698

Q37974686-31727621-40D5-41FE-B8BC-02F4CF3125A1

P356

14740338.2012.650164

P1433

Expert Opinion on Drug Safety

P1476

Bleeding risk and safety profile related to the use of eptifibatide: a current review.

@en

P2093

Costin Ionescu

http://www.w3.org/2001/XMLSchema#string

Fadi Saab

http://www.w3.org/2001/XMLSchema#string

Marc J Schweiger

http://www.w3.org/2001/XMLSchema#string

P2860

Integrin bidirectional signaling: a molecular view

Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial

Abciximab readministration: results of the ReoPro Readministration Registry

Long-term efficacy of platelet glycoprotein IIb/IIIa integrin blockade with eptifibatide in coronary stent intervention

Bivalirudin for patients with acute coronary syndromes

An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The GUSTO investigators

Bivalirudin during primary PCI in acute myocardial infarction

Incidence of intracranial hemorrhage complicating treatment with glycoprotein IIb/IIIa receptor inhibitors: a pooled analysis of major clinical trials.

Thrombocytopenia caused by abciximab or tirofiban and its association with clinical outcome in patients undergoing coronary stenting.

Frequency and management of thrombocytopenia with the glycoprotein IIb/IIIa receptor antagonists.

P304

315-324

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14740338.2012.650164

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P577

2012-01-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22233272

http://www.w3.org/2001/XMLSchema#string